GARY WALSH THOMAS
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- Bluffton, SC
- NPI
- 1043218316
- Received
- $48,828 in 636 records, 2019 to 2025 ($47,309 general, $1,518 research)
- As principal investigator
- $52,581 of research payments to others in 39 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 107 | $5,947 |
| 2024 | General payment | 161 | $11,797 |
| 2023 | General payment | 122 | $2,754 |
| 2023 | Research payment | 1 | $1,518 |
| 2022 | General payment | 102 | $6,166 |
| 2021 | General payment | 40 | $6,700 |
| 2020 | General payment | 27 | $3,393 |
| 2019 | General payment | 76 | $10,550 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 14 | $23,605 |
| Food and Beverage | 597 | $14,218 |
| Honoraria | 4 | $4,050 |
| Travel and Lodging | 8 | $3,030 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $2,000 |
| Research payment | 1 | $1,518 |
| Education | 11 | $406 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-12-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $162 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-17 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | Lunsumio Biological, BioOncology | 2025 | |
| 2025-12-16 | ARRAY BIOPHARMA INC | $25 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-12-11 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-12-02 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-11-24 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-11-18 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-11-14 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-11-13 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-11-11 | Daiichi Sankyo Inc. | $27 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-11-10 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-11-08 | AVYXA PHARMA, LLC | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-08 | AVYXA PHARMA, LLC | $681 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-08 | AVYXA PHARMA, LLC | $440 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-08 | AVYXA PHARMA, LLC | $177 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-08 | AVYXA PHARMA, LLC | $89 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-04 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | BLENREP Biological, ONCOLOGY | 2025 | |
| 2025-10-31 | BeOne Medicines USA, Inc. | $31 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-10-27 | Pharmacosmos Therapeutics Inc. | $19 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-10-23 | PharmaEssentia USA Corporation | $25 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-10-22 | Gilead Sciences, Inc. | $29 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-10-21 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-10-16 | Daiichi Sankyo Inc. | $27 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-10-09 | Incyte Corporation | $22 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-10-08 | BeOne Medicines USA, Inc. | $21 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-07 | Eisai Inc. | $13 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-10-02 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-09-30 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-09-25 | BeOne Medicines USA, Inc. | $19 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-09-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-18 | Genmab U.S., Inc. | $24 | Food and Beverage | In-kind items and services | Epkinly Drug, Oncology | 2025 | |
| 2025-09-16 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-09-11 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-09-04 | Aveo Pharmaceuticals, Inc. | $33 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-09-03 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-09-03 | EMD Serono, Inc. | $17 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-08-26 | TAIHO ONCOLOGY, INC. | $26 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-08-21 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-08-19 | Exelixis Inc. | $23 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-08-14 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-08-13 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-08-12 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-08-07 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-08-05 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-07-31 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-07-24 | Merck Sharp & Dohme LLC | $30 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-23 | BeOne Medicines USA, Inc. | $29 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-07-23 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-07-17 | Adaptive Biotechnologies Corporation | $16 | Food and Beverage | Cash or cash equivalent | clonoSEQ Device, Devices | 2025 | |
| 2025-07-15 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-07-14 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-07-11 | Iovance Biotherapeutics, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-07-10 | ARRAY BIOPHARMA INC | $25 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-07-08 | Ipsen Biopharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2025 | |
| 2025-07-01 | Rigel Pharmaceuticals, Inc. | $29 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-06-19 | SOBI, INC | $26 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-06-17 | Merck Sharp & Dohme LLC | $30 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-06-12 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-06-11 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-06-10 | BeOne Medicines USA, Inc. | $34 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-06-05 | GENZYME CORPORATION | $36 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-06-03 | SOBI, INC | $16 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-05-30 | Aveo Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-05-29 | Eisai Inc. | $20 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-05-27 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-22 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-15 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-05-14 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-13 | Karyopharm Therapeutics Inc. | $24 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-05-08 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-08 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-05-06 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-05-01 | Legend Biotech USA Inc. | $38 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-04-30 | ARRAY BIOPHARMA INC | $19 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-04-29 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-04-25 | Merck Sharp & Dohme LLC | $31 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-22 | TAIHO ONCOLOGY, INC. | $30 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-04-17 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-04-15 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-04-10 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-04-08 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-04-03 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2025 | |
| 2025-04-01 | Adaptive Biotechnologies Corporation | $16 | Food and Beverage | Cash or cash equivalent | clonoSEQ Device, Devices | 2025 | |
| 2025-03-28 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-03-27 | Incyte Corporation | $16 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-03-25 | Iovance Biotherapeutics, Inc. | $32 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-03-25 | Merck Sharp & Dohme LLC | $7 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-03-24 | Merck Sharp & Dohme LLC | $9 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-03-14 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-03-14 | AstraZeneca Pharmaceuticals LP | $0 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-03-13 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2025 | |
| 2025-03-11 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-03-06 | TAIHO ONCOLOGY, INC. | $29 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-03-04 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-02-27 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-02-26 | Eisai Inc. | $18 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-20 | Acrotech Biopharma Inc. | $27 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-02-13 | Daiichi Sankyo Inc. | $28 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-02-11 | Eisai Inc. | $24 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-06 | AstraZeneca Pharmaceuticals LP | $99 | Education | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-02-06 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-01-30 | Takeda Pharmaceuticals U.S.A., Inc. | $33 | Food and Beverage | In-kind items and services | ALUNBRIG Drug, ONCOLOGY | 2025 | |
| 2025-01-16 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-01-09 | Stemline Therapeutics Inc. | $18 | Food and Beverage | In-kind items and services | ELZONRIS Drug, Oncology | 2025 | |
| 2025-01-07 | Janssen Biotech, Inc. | $25 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2024-12-19 | Karyopharm Therapeutics Inc. | $23 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2024 | |
| 2024-12-19 | Aveo Pharmaceuticals, Inc. | $20 | Education | In-kind items and services | FOTIVDA Drug, Oncology | 2024 | |
| 2024-12-18 | SOBI, INC | $16 | Food and Beverage | In-kind items and services | SYNAGIS Drug, IMMUNOLOGY | 2024 | |
| 2024-12-16 | Novartis Pharmaceuticals Corporation | $29 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-12-16 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-12-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-12 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-12-11 | Novocure Inc. | $125 | Food and Beverage | Cash or cash equivalent | Optune Lua (NovoTTF-200T) Device, Oncology | 2024 | |
| 2024-12-11 | JAZZ PHARMACEUTICALS INC. | $17 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-12-04 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2024 | |
| 2024-12-03 | Merck Sharp & Dohme LLC | $27 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-11-26 | BeiGene USA, Inc. | $22 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-11-26 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2024 | |
| 2024-11-20 | TAIHO ONCOLOGY, INC. | $23 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-11-19 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-11-14 | Merck Sharp & Dohme LLC | $28 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-11-09 | Incyte Corporation | $20 | Food and Beverage | Cash or cash equivalent | PEMAZYRE Drug, Hepatology (Liver, Pancreatic, Gall Bladder) | 2024 | |
| 2024-11-07 | Rigel Pharmaceuticals, Inc. | $22 | Food and Beverage | Cash or cash equivalent | Rezlidhia Drug, Acute Myeloid Leukemia | 2024 | |
| 2024-11-05 | Novocure Inc. | $28 | Food and Beverage | Cash or cash equivalent | Optune Lua (NovoTTF-200T) Device, Oncology | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2024 | |
| 2024-10-31 | ARRAY BIOPHARMA INC | $23 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2024 | |
| 2024-10-31 | Celgene Corporation | $22 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-10-30 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-10-29 | Tempus AI, Inc | $59 | Food and Beverage | In-kind items and services | XT CDX Device, NONE | 2024 | |
| 2024-10-28 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-10-25 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-10-24 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | CALQUENCE Drug, Oncology | 2024 | |
| 2024-10-24 | Merck Sharp & Dohme LLC | $30 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-10-23 | Daiichi Sankyo Inc. | $23 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-10-22 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | ALUNBRIG Drug, ONCOLOGY | 2024 | |
| 2024-10-16 | Deciphera Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | QINLOCK Drug, ONCOLOGY | 2024 | |
| 2024-10-15 | Celgene Corporation | $27 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-15 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-14 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-10-10 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-10-08 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-09-24 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-09-23 | PUMA BIOTECHNOLOGY, INC. | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-18 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-09-17 | Lilly USA, LLC | $29 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-09-17 | ARRAY BIOPHARMA INC | $13 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2024 | |
| 2024-09-16 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-09-13 | Coherus Oncology, Inc. | $19 | Food and Beverage | In-kind items and services | Udenyca Biological, Granulocyte colony stimulating factor | 2024 | |
| 2024-09-11 | Genmab U.S., Inc. | $31 | Food and Beverage | In-kind items and services | Tivdak Drug, Oncology | 2024 | |
| 2024-09-10 | PFIZER INC. | $30 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-09-09 | PharmaEssentia USA Corporation | $15 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2024 | |
| 2024-09-05 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-09-05 | Celgene Corporation | $11 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-09-04 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-09-03 | Gilead Sciences, Inc. | $32 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-29 | Genentech USA, Inc. | $28 | Food and Beverage | In-kind items and services | Columvi Biological, BioOncology | 2024 | |
| 2024-08-28 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2024 | |
| 2024-08-27 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-08-26 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2024 | |
| 2024-08-26 | SOBI, INC | $18 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-08-22 | SERVIER PHARMACEUTICALS LLC | $16 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2024 | |
| 2024-08-20 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-08-19 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-08-15 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-08-15 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2024 | |
| 2024-08-13 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-13 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-08-12 | TAIHO ONCOLOGY, INC. | $20 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-07-31 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-07-31 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-07-30 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-07-25 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2024 | |
| 2024-07-23 | Merck Sharp & Dohme LLC | $26 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-07-18 | PharmaEssentia USA Corporation | $17 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2024 | |
| 2024-07-17 | BeiGene USA, Inc. | $28 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-07-15 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-07-10 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | MEKINIST Drug, Oncology | 2024 | |
| 2024-07-09 | Astellas Pharma US Inc | $24 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2024 | |
| 2024-07-03 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2024 | |
| 2024-07-02 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-07-01 | Merck Sharp & Dohme LLC | $25 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-06-27 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-06-27 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2024 | |
| 2024-06-27 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2024 | |
| 2024-06-26 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-06-25 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2024 | |
| 2024-06-24 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-06-20 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-06-19 | Merck Sharp & Dohme LLC | $30 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-06-18 | Ipsen Biopharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2024 | |
| 2024-06-11 | Eisai Inc. | $24 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-06-11 | Incyte Corporation | $21 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2024 | |
| 2024-06-10 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2024 | |
| 2024-06-07 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-06-05 | SUN PHARMACEUTICAL INDUSTRIES INC. | $56 | Food and Beverage | In-kind items and services | YONSA Drug, Oncology | 2024 | |
| 2024-06-04 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-06-03 | Alexion Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-05-31 | BeiGene USA, Inc. | $2,625 | Consulting Fee | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2024 |
The latest 200 records of 636.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2024-12-12 | E.R. Squibb & Sons, L.L.C. | South Carolina Cancer Specialists, Pa | $8,625 | Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice | 2024 |
| 2024-05-28 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $6,450 | realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients Wi | 2024 |
| 2023-12-31 | Merck Sharp & Dohme LLC | S. Carolina Cancer Specialists PC | $435 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2023 |
| 2022-12-31 | Merck Sharp & Dohme LLC | S. Carolina Cancer Specialists PC | $149 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2022 |
| 2022-04-06 | E.R. Squibb & Sons, L.L.C. | South Carolina Cancer Specialists, Pa | $137 | Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice | 2022 |
| 2021-12-31 | Merck Sharp & Dohme LLC | S. Carolina Cancer Specialists PC | $2,779 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-07-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL) | 2021 |
| 2021-05-26 | E.R. Squibb & Sons, L.L.C. | South Carolina Cancer Specialists, Pa | $1,256 | Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice | 2021 |
| 2021-04-24 | Amgen Inc. | SAINT JOSEPHS CANDLER SOUTH CAROLINA CANCER SPECIALISTS | $250 | Prospective Observational Study of Onpro vs SOC. | 2021 |
| 2021-01-20 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $697 | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2021 |
| 2020-11-18 | E.R. Squibb & Sons, L.L.C. | South Carolina Cancer Specialists, Pa | $968 | Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice | 2020 |
| 2020-03-21 | Amgen Inc. | SAINT JOSEPHS CANDLER SOUTH CAROLINA CANCER SPECIALISTS | $4,110 | Prospective Observational Study of Onpro vs SOC. | 2020 |
| 2020-01-30 | Amgen Inc. | SOUTH CAROLINA CANCER SPECIALISTS | $2,116 | Prospective Observational Study of Onpro vs SOC. | 2020 |
| 2020-01-28 | E.R. Squibb & Sons, L.L.C. | ORLANDO HEALTH | $675 | A US Multi-Site Observational Study in Patients With Unresectable And Metastatic Melanoma: The OPTIMIzE Study | 2020 |
| 2020-01-22 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $767 | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 |
| 2019-12-24 | Amgen Inc. | SOUTH CAROLINA CANCER SPECIALISTS | $222 | Prospective Observational Study of Onpro vs SOC | 2019 |
| 2019-12-12 | PUMA BIOTECHNOLOGY, INC. | SOUTH CAROLINA CANCER SPECIALISTS PA | $2,800 | A Randomized, Double-Blind, Placebo-Controlled Trial Of Neratinib | 2019 |
| 2019-12-04 | Amgen Inc. | SAINT JOSEPHS CANDLER SOUTH CAROLINA CANCER SPECIALISTS | $2,524 | NSCLC | 2019 |
| 2019-10-22 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $50 | PCYC-1134M-CA | 2019 |
| 2019-08-22 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-08-08 | E.R. Squibb & Sons, L.L.C. | South Carolina Cancer Specialists, Pa | $4,462 | Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices | 2019 |
| 2019-07-19 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-07-10 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $22 | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 |
| 2019-07-10 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $32 | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-05-02 | Amgen Inc. | SOUTH CAROLINA CANCER SPECIALISTS | $10,010 | Prospective Observational Study of Onpro vs SOC | 2019 |
| 2019-04-29 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $220 | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-03-26 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-02-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-02-15 | Pharmacyclics LLC, an AbbVie Company | SOUTH CAROLINA CANCER SPECIALISTS PA | $150 | PCYC-1134M-CA | 2019 |
| 2019-02-05 | Incyte Corporation | SOUTH CAROLINA CANCER SPECIALISTS | $220 | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-02-04 | PUMA BIOTECHNOLOGY, INC. | SOUTH CAROLINA CANCER SPECIALISTS PA | $500 | A Randomized, Double-Blind, Placebo-Controlled Trial of Neratinib | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bluffton, SC, county Beaufort County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Bluffton, SC | County Beaufort County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 33,157 | 195,289 | 5,296,225 |
| Population, 2020 census P1 | 27,716 | 187,117 | 5,118,425 |
| Median age B01002 | 42.7 | 48.1 | 40.2 |
| Under 18 B01001 | 22.7% | 17.4% | 21.4% |
| 65 and over B01001 | 24.6% | 28.4% | 18.9% |
| Households B11001 | 12,987 | 82,333 | 2,117,989 |
| Foreign born B05002 | 5.7% | 7.7% | 5.8% |
| Median household income B19013 | $111,281 | $86,573 | $69,324 |
| Median family income B19113 | $124,654 | $106,673 | $86,707 |
| Per capita income B19301 | $63,413 | $53,951 | $39,236 |
| Poverty rate B17001 | 4.3% | 9.6% | 14.1% |
| Unemployment rate B23025 | 2.2% | 2.6% | 4.9% |
| Civilian labor force B23025 | 15,757 | 85,152 | 2,560,429 |
| Mean commute (minutes) B08013 | 28.3 | 23.6 | 25.6 |
| Bachelor's degree or higher B15003 | 51.9% | 46.0% | 32.1% |
| Housing units B25001 | 13,882 | 103,177 | 2,443,039 |
| Owner-occupied B25003 | 83.4% | 75.9% | 71.9% |
| Renters B25003 | 16.6% | 24.1% | 28.1% |
| Median home value B25077 | $492,100 | $455,600 | $259,000 |
| Median gross rent B25064 | $2,256 | $1,653 | $1,180 |
| White, not Hispanic B03002 | 74.8% | 67.3% | 61.9% |
| Black B03002 | 9.0% | 15.5% | 24.6% |
| Hispanic or Latino B03002 | 10.5% | 12.4% | 7.4% |
| Asian B03002 | 1.4% | 1.1% | 1.7% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bluffton, SC.
Comments